Live feed02:06:00·4dPRReleasevia QuantisnowIonis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis BByQuantisnow·Wall Street's wire, on your screen.IONS· Ionis Pharmaceuticals Inc.Health Care
